Related references
Note: Only part of the references are listed.Rates of Adverse IBD-Related Outcomes for Patients With IBD and Concomitant Prostate Cancer Treated With Radiation Therapy
Linda A. Feagins et al.
INFLAMMATORY BOWEL DISEASES (2020)
Stereotactic body radiotherapy with periprostatic hydrogel spacer for localized prostate cancer: toxicity profile and early oncologic outcomes
Mark E. Hwang et al.
RADIATION ONCOLOGY (2019)
Five-Year Outcomes of a Phase 1 Dose-Escalation Study Using Stereotactic Body Radiosurgery for Patients With Low-Risk and Intermediate-Risk Prostate Cancer
Michael J. Zelefsky et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
Absorbable Hydrogel Spacer Use in Prostate Radiotherapy: A Comprehensive Review of Phase 3 Clinical Trial Published Data
Lawrence I. Karsh et al.
UROLOGY (2018)
The Rectal Dosimetric Effects of Perirectal Hydrogel Spacers in Men Undergoing Prostate Stereotactic Body Radiation Therapy (SBRT)
S. Kataria et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Continued Benefit to Rectal Separation for Prostate Radiation Therapy: Final Results of a Phase III Trial
Daniel A. Hamstra et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Hydrogel spacer distribution within the perirectal space in patients undergoing radiotherapy for prostate cancer: Impact of spacer symmetry on rectal dose reduction and the clinical consequences of hydrogel infiltration into the rectal wall
Benjamin W. Fischer-Valuck et al.
PRACTICAL RADIATION ONCOLOGY (2017)
Hydrogel Spacer Prospective Multicenter Randomized Controlled Pivotal Trial: Dosimetric and Clinical Effects of Perirectal Spacer Application in Men Undergoing Prostate Image Guided Intensity Modulated Radiation Therapy
Neil Mariados et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
Urethrogram-directed stereotactic body radiation therapy for clinically localized prostate cancer in patients with contraindications to magnetic resonance imaging
Ima Paydar et al.
FRONTIERS IN ONCOLOGY (2015)
MRI for Patients with Cardiac Implantable Electrical Devices
Grant V. Chow et al.
CARDIOLOGY CLINICS (2014)
Proctitis following stereotactic body radiation therapy for prostate cancer
Daniel Y. Joh et al.
RADIATION ONCOLOGY (2014)
Absorbable hydrogel spacer use in men undergoing prostate cancer radiotherapy: 12 month toxicity and proctoscopy results of a prospective multicenter phase II trial
Matthias Uhl et al.
RADIATION ONCOLOGY (2014)
Quality of life and toxicity after SBRT for organ-confined prostate cancer, a 7-year study
Alan Jay Katz et al.
FRONTIERS IN ONCOLOGY (2014)
Stereotactic Body Radiation Therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience
Leonard N. Chen et al.
RADIATION ONCOLOGY (2013)
Impact of magnetic resonance imaging on computed tomography-based treatment planning and acute toxicity for prostate cancer patients treated with intensity modulated radiation therapy
Arif N. Ali et al.
PRACTICAL RADIATION ONCOLOGY (2013)
Aspirin Use and the Risk of Prostate Cancer Mortality in Men Treated With Prostatectomy or Radiotherapy
Kevin S. Choe et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Six-dimensional correction of intra-fractional prostate motion with CyberKnife stereotactic body radiation therapy
Siyuan Lei et al.
FRONTIERS IN ONCOLOGY (2011)
RADIOGRAPHIC AND ANATOMIC BASIS FOR PROSTATE CONTOURING ERRORS AND METHODS TO IMPROVE PROSTATE CONTOURING ACCURACY
Patrick W. McLaughlin et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
EXTERNAL BEAM RADIOTHERAPY FOR PROSTATE CANCER PATIENTS ON ANTICOAGULATION THERAPY: HOW SIGNIFICANT IS THE BLEEDING TOXICITY?
Kevin S. Choe et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Time course of late rectal toxicity after radiation therapy for prostate cancer
K. Odrazka et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2010)
A Pilot Study of Intensity Modulated Radiation Therapy with Hypofractionated Stereotactic Body Radiation Therapy (SBRT) Boost in the Treatment of Intermediate- to High-Risk Prostate Cancer
Eric K. Oermann et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2010)
Anatomic-based three-dimensional planning precludes use of catheter-delivered contrast for treatment of prostate cancer
Melisa Boersma et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Intrafractional motion of the prostate during hypofractionated radiotherapy
Yaoqin Xie et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Frequency of referral of patients with safety-related contraindications to magnetic resonance imaging
Marc Dewey et al.
EUROPEAN JOURNAL OF RADIOLOGY (2007)
Patient and treatment factors associated with complications after prostate brachytherapy
Aileen B. Chen et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Functional anatomy of the prostate: Implications for treatment planning
PW McLaughlin et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
Intraprostatic fiducials for localization of the prostate gland: Monitoring intermarker distances during radiation therapy to test for marker stability
PA Kupelian et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
Magnetic resonance imaging anatomy of the prostate and periprostatic area: a guide for radiotherapists
GM Villeirs et al.
RADIOTHERAPY AND ONCOLOGY (2005)
Marker seed migration in prostate localization
MM Poggi et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2003)
(Non)-migration of radiopaque markers used for on-line localization of the prostate with an electronic portal imaging device
J Pouliot et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2003)
Reduction of dose delivered to the rectum and bulb of the penis using MRI delineation for radiotherapy of the prostate
RJHM Steenbakkers et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2003)
Fiducial-based targeting accuracy for external-beam radiotherapy
MJ Murphy
MEDICAL PHYSICS (2002)